The protective effect of cetirizine against bleomycine induced pulmonary fibrosis in rats

Pakistan Journal of Medical Sciences

Volumn 24, Issue 6, 2008, Pages 813-820

  Hemmati, Ali Asghar ^a   Mikaili, Peyman ^a   Khodayar, Mohammad Javad ^a   Ghafurian, Mehri ^a   Rashidi, Iran ^a  

^a AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Bleomycine; Cetirizine; Cytokines; Pulmonary fibrosis

Indexed keywords

BLEOMYCIN; CETIRIZINE; COLLAGEN; HYDROXYPROLINE; INTERLEUKIN 8; SODIUM CHLORIDE; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMOPROPHYLAXIS; CHRONOTHERAPY; CONTROLLED STUDY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; LUNG FIBROSIS; LUNG PARENCHYMA; MALE; NONHUMAN; PROTECTION; PROTEIN LOCALIZATION; RAT; SINGLE DRUG DOSE; SPRAGUE DAWLEY RAT;

EID: 57649100168     PISSN: 1682024X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Razzaque MS, Taguchi T. Pulmonary fibrosis: Cellular and molecular events. Pathology International, 2003;53(3):133-145.
2. Ian YR. Adamson. Drug-Induced Pulmonary Fibrosis. Environmental Health Perspectives 1984;55:25-36.
3. Kalayarasan S, Sriram N, Sudhandiran G. Diallyl sulfide attenuates bleomycin-induced pulmonary fibrosis: Critical role of iNOS, NF-kappaB, TNF-alpha and IL-1beta. Life Sci 2008;82(23-24):1142-53.
4. Li X, Molina-Molina M, Abdul-Hafez A, Uhal V, Xaubet A, Uhal BD. Angiotensin converting enzyme-2 is protective but downregulated in human and experimental lung fibrosis. Am J Physiol Lung Cell Mol Physiol 2008;295(1):178-85.
5. Nakashima T, Yokoyama A, Onari Y, Shoda H, Haruta Y, Hattori N, et al. Suppressor of cytokine signaling 1 inhibits pulmonary inflammation and fibrosis. J Allergy Clin Immunol 2008;121(5):1269-76.
6. Andrade RS, Kesler KA, Wilson JL, Brooks JA, Reichwage BD. Short and long term outcomes after large pulmonary resection for germ cell tumors after bleomycin-combination chemotherapy. Ann Thorac Surg 2004;78(4):1224-8.
7. 1 antihistamines. J Investig Allergol Clin Immunol 2006;16: Supplement 1:29-36.
8. Schraufnagel DE, Mehta D, Harsbarger R, Trevianus K, Wang NS. Capillary remodelling in bleomycin induced pulmonary fibrosis. Am J Pathol 1986;125:97-106.
9. Hemmati AA, Nazari Z, Motlagh ME, Goldasteh S. The role of sodium cromolyn in treatment of paraquat-induced pulmonary fibrosis in rat. Pharmacological Research 2002;46(3):229-34.
10. Larsson AK, Fumagalli F, DiGennaro A, Andersson M, Lundberg J, Edenius C, et al. A new class of nitric oxide-releasing derivatives of cetirizine; pharmacological profile in vascular and airway smooth muscle preparations. Br J Pharmacol 2007;151(1):35-44.
11. Orzechowski RF, Currie DS, Valancius CA. Comparative anticholinergic activities of 10 histamine H1 receptor antagonists in two functional models. Eur J Pharmacol 2005;506(3):257-64.
12. Zhang Y, Lee TC, Guillemin B. Enhanced IL-1β and tumor necrosis factor-α release and messenger RNA expression in macrophages from idiopathic pulmonary fibrosis or after asbestosis exposure. J Immunol 1993;150:4188-96.
13. Pinart M, Serrano-Mollar A, Negri EM, Cabrera R, Rocco PR, Romero PV. Inflammatory related changes in lung tissue mechanics after bleomycin-induced lung injury. Respir Physiol Neurobiol 2008;160(2):196-203. Epub 2007.
14. Hemmati AA, Hicks R. Increased myofibroblast contractile sensitivity in paraquat pretreated rat lung tissue. Life Sci 1999;65:2325-32.
15. Hübner RH, Gitter W, Eddine El, Mokhtari N, Mathiak M, Both M, et al. Standardized quantification of pulmonary fibrosis in histological samples. Biotechniques 2008;44(4):507-17.
16. Hübner RH, Gitter W, El Mokhtari NE, Mathiak M. Standardized quantification of pulmonary fibrosis in histological samples. Biotechniques 2008;44(4):507-17.
17. Crouch EC. Pathobiology of pulmonary fibrosis. Am J Physiol 1990;259:159-84.
18. Sime PJ, O'Reilly KMA. Fibrosis of the lung and other tissues: New concepts in pathogenesis and treatment. Clin Immunol 2001;99:308-19.
19. Raghu G, Masta S, Meyers D, Narayanan AS. Collagen synthesis by normal and fibrotic human lung fibroblasts and the effect of transforming growth factor. Am Rev Respir Dis 1989;140:95-100.
20. De Vos C, Mitchev K, Pinelli ME, Derde MP, Boev R. Non-interventional study comparing treatment satisfaction in patients treated with antihistamines. Clin Drug Investig 2008;28(4):221-30.
21. Wallach-Dayan SB, Golan-Gerstl R, Breuer R. Evasion of myofibroblasts from immune surveillance: A mechanism for tissue fibrosis. Proc Natl Acad Sci USA. 2007;18;104(51):20460-5.
22. Grönke L, Schlenker J, Holz O, Magnussen H, Jörres RA. Effect of cetirizine dihydrochloride on the airway response to hypertonic saline aerosol in patients with chronic obstructive pulmonary disease (COPD). Respiratory Medicine 2005;99(10):1241-8.
23. Noah TL, Paradiso AM, Madden MC, McKinnon KP, Devlin RB. The response of a human bronchial epithelial cell line to histamine: Intracellular calcium changes and extracellular release of inflammatory mediators. Am J Respir Cell Mol Biol 1991;5(5):484-92.
24. Kang HR, Cho SJ, Lee CG, Homer RJ, Elias JA. Transforming growth factor (TGF)-beta1 stimulates pulmonary fibrosis and inflammation via a Bax-dependent, bid-activated pathway that involves matrix metalloproteinase-12. J Biol Chem 2007;282(10):7723-32.
25. Cheng KC, Hsu JY, Fu LS, Chang WC, Chu JJ. Influence of cetirizine and loratadine on granulocyte-macrophage colony-stimulating factor and interleukin-8 release in A549 human airway epithelial cells stimulated with interleukin-1beta. J Microbiol Immunol Infect 2006;39(3):206-11.